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Bioluminescence imaging allows spatial and temporal progression of viral infection to be detected and quantified in living mice, thereby
providing a new approach for studies of viral–host pathogenesis. It has been necessary to construct and validate recombinant reporter viruses that
express firefly luciferase to investigate viral replication and spread with this imaging technology. This strategy greatly limits the ability to analyze
multiple strains of virus and/or existing viral mutants, and reporter viruses also may be attenuated relative to the respective parental viruses. To
facilitate bioluminescence imaging of herpes simplex virus type 1 (HSV-1), we developed a transgenic reporter mouse that uses the promoter from
HSV-1 thymidine kinase to control expression of firefly luciferase. Infection with HSV-1 activated expression of firefly luciferase in corneal and flank
models of infection, and amounts of bioluminescence increased in proportion to increasing input titers of virus. Imaging could detect infection with
three different strains of HSV-1 with the following relative rank order of bioluminescence produced at the site of infection: McKrae N 17 N KOS.
Corneal infection with as few as 1 × 103 pfu strainMcKrae was detectable above background levels. By comparison, infection with vaccinia virus did
not affect bioluminescence in the reporter mouse. Collectively, these data establish a new transgenic reporter mouse for infection with HSV-1, thereby
enabling in vivo bioluminescence imaging studies of HSV-1 pathogenesis without constructing new reporter viruses.
© 2005 Elsevier Inc. All rights reserved.Keywords: Herpes simplex virus type 1; Bioluminescence imaging; Transgenic mouseHerpes simplex virus type 1 (HSV-1) is a neurotropic human
pathogen that infects more than 80% of adults. Typically, HSV-
1 produces lytic infection in the cornea or other localized
epithelial site followed by entry into peripheral nerves and
retrograde transport to sensory nerve ganglia. Further viral
replication may occur within ganglia, but ultimately viral gene
expression is repressed and latency is established.
HSV-1 infection also can spread systemically, particularly in
neonates and patients with AIDS, cancer, organ transplantation,
or other immunocompromising diseases (Irie et al., 1998;
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doi:10.1016/j.virol.2005.12.016disseminated herpes infection frequently is delayed in patients
(Kimberlin et al., 2001), particularly those without skin lesions
(Arvin et al., 1982). Because optimal therapy with antiviral
drugs must be initiated before widespread dissemination of
virus (Whitley et al., 1991), systemic HSV-1 infection produces
significant morbidity and mortality (Kimura et al., 2002).
Twenty-five percent of neonates with herpes infection develop
disseminated infection, and approximately 30% of these
patients die from the disease (Kimberlin, 2004). Therefore,
improved understanding of HSV-1 viral–host pathogenesis and
immune responses to HSV-1 is needed to identify patients at
risk for disseminated infection and develop new therapies for
persons with systemic disease.
We previously used bioluminescence imaging (BLI) to
investigate infection with a recombinant strain KOS virus that
expresses firefly luciferase (FL) under control of the promoter
Fig. 1. Regulation of various HSV-1 promoters in vitro. 293T (A) or Vero cells
(B) in 24-well plates were transfected transiently with plasmids containing
various HSV-1 promoters linked to firefly luciferase. Cells were infected with
strain KOS at an MOI of 5 (open bars) or mock-infected (black bars) 24 h after
transfection, and relative amounts of luciferase activity in cell lysates were
quantified 24 h after infection. Relative light units for luciferase activity were
normalized to mg protein in each sample. Bars on the far right of each graph are
data from cells infected with strain KOS or KOS/dlux, a recombinant virus that
expresses firefly luciferase from the ICP8 promoter. Data are mean
values ± SEM for n = 4 samples each, and presented data are representative
of 2 independent experiments.
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BLI enables the spatial and temporal progression of infection to
be monitored in living mice. Because relative amounts of
bioluminescence correlate directly with titers of virus, this
system can be used to interrogate effects of host immunity on
pathogenesis or quantify effects of antiviral therapy. For
example, BLI studies have allowed us to establish functions
of type I and II interferons in preventing systemic dissemination
of HSV-1 (Luker et al., 2003).
Previous studies of viral–host pathogenesis with BLI
performed by our laboratory and others have used recombinant
viruses that express FL (Cook and Griffin, 2003; Luker et al.,
2005). This strategy necessitates that a new reporter virus must
be constructed to assay pathogenesis of a different strain of
virus or a virus with targeted deletion of a specific gene. As an
alternative approach to facilitate BLI studies of HSV-1, we
developed a transgenic mouse carrying a reporter that produces
bioluminescence in response to HSV-1 infection. The transgene
is comprised of the −121 to +52 bases of the promoter from
HSV-1 thymidine kinase (TK) linked to firefly luciferase. In
response to infection with three different strains of HSV-1,
activity of FL in transgenic mice reproduced the established
spatial and temporal progression of HSV-1 infection. Amounts
of bioluminescence increased with increasing input titers of
virus, showing that the TK-FL reporter mouse can be used to
quantify relative differences in virus in vivo. Collectively, these
data establish the TK-FL reporter mouse for BLI studies of
HSV-1 in living mice, allowing studies of viral–host pathogen-
esis to be accomplished without constructing reporter viruses.
Results
In vitro analysis of HSV-1 luciferase reporters
An optimal HSV-1 promoter-FL reporter construct for
detecting infection in vivo with BLI would have low levels of
expression under basal conditions and high induction of FL in
response to infection with HSV-1. As candidate reporter
constructs for imaging, we generated plasmids that used
promoters from ICP6, ICP8, or thymidine kinase from HSV-1
to regulate expression of FL. The ICP6 promoter has been used
previously to develop a sensitive reporter cell line for detecting
HSV-1 infection in vitro (Olivo, 1994), while ICP8 is the
promoter that controls expression of FL in our reporter virus,
KOS/dlux (Summers et al., 2001). While the TK promoter may
be used to drive low levels of expression of target genes in
cultured cells (Hua et al., 1996), this promoter also induces high
levels of reporter gene activity in response to infection with
HSV-1 (Mosca et al., 1985; Smiley et al., 1987).
To compare these 3 different promoters for expression of FL
under basal conditions and after infection with HSV-1, we
transiently transfected 293T or Vero cells with each reporter
plasmid. Twenty-four hours after transfection, cells were
infected with strain KOS at an MOI of 5 or mock-infected.
Bioluminescence from FL in the absence or presence of
infection was quantified 24 h after infection. Cells also were
infected with KOS or KOS/dlux as negative and positivecontrols for background bioluminescence and robust induction
of FL, respectively. The TK-FL reporter had the lowest basal
expression of FL and highest induction of bioluminescence after
infection among the three reporter constructs (Fig. 1). For the
TK-FL reporter, luciferase activity increased by approximately
50 to 160-fold in cells infected with strain KOS relative to
uninfected cells. By comparison, bioluminescence from KOS/
dlux was approximately 104 greater than cells infected with
strain KOS. The greater net increase in FL with KOS/dlux
primarily is due to the lower bioluminescence in uninfected
cells relative to the reporter plasmids. Similar data were
obtained with infections at an MOI of 1 (data not shown).
Based on these data, we selected the TK-FL reporter for
developing a transgenic reporter mouse for imaging infection
with HSV-1.
We also used the ICP6-FL reporter construct to prepare a
transgenic mouse. This selection was based upon the published
success for detecting infection with HSV-1 in cells that have this
reporter stably integrated into the genome. Because regulatory
elements for genes are known to function differently in
transiently versus stably transfected cells (Berland and Chasin,
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might be improved as a transgene integrated into the genome.
In vivo screening of founder mice
Our initial strategy was to establish transgenic reporter mice
in inbred and outbred strains of mice. This approach would
allow us to exploit genetically engineered inbred mice for
studies of HSV-1 pathogenesis and also have a model that
reproduces the genetic heterogeneity of human populations
infected with the virus. We obtained 4 founder mice in a hybrid
strain of C57BL/6 and C3H that had germline transmission of
the TK-FL transgene, and 3 founder CD-1 mice carried the
ICP6-FL reporter. Mice with either transgene appeared normal
phenotypically, suggesting that the transgenes had no deleteri-
ous effects on the mice.
We used BLI imaging to monitor expression of FL under
basal conditions and in response to corneal infection with
strain 17 HSV-1. Mice were infected with 1 × 106 pfu strain
17 by corneal scarification in the right eye, while the left eye
of each mouse was mock-infected as a control for non-
specific induction of FL. Qualitative and quantitative
expression and distribution of bioluminescence in each eye
were assayed with BLI performed 1 day prior to infection and
daily for 8 days post-infection. Representative images from
each line of TK-FL transgenic mice on day 5 after infection
are shown in Fig. 2A.
Each of the four lines of TK-FL transgenic mice showed
increased bioluminescence in the infected right eye and
periocular tissues. This distribution reproduced the expected
progression of ocular infection with HSV-1 in mice as
determined with KOS/dlux, although we cannot validate that
every cell infected with HSV-1 also produces bioluminescence.
By region-of-interest (ROI) analysis, the relative increase in FL
activity produced by infection ranged from approximately 3-
fold in line 2 to 30-fold in line 4. Mock-infected left eyesFig. 2. Characterization of four founder lines of TK-FL transgenic reporter mice. (A)
the right eye with 1 × 106 pfu strain 17 HSV-1. Representative BLI images of mice f
Images of the mock-infected left eye of each mouse also are presented. Bioluminescen
and lowest amounts of photon flux, respectively. (B) Representative image of a mou
1 × 106 pfu strain WR vaccinia virus.showed no detectable increase in bioluminescence in any of the
four lines of TK-FL transgenic mice (Fig. 2A). As a control for
specificity, we infected TK-FL transgenic mice with vaccinia
virus, an unrelated DNA virus that also encodes a thymidine
kinase gene. Unlike infection with HSV-1, corneal infection
with vaccinia virus did not affect bioluminescence in TK-FL
transgenic mice (Fig. 2B). These data show that transgenic mice
with the TK-FL transgene were not general reporters of viral
infection. BLI imaging also showed a variable amount of
bioluminescence in the absence of infection in TK-FL mice.
This background bioluminescence was observed predominantly
in the paws and tail, although FL activity also could be detected
in the ears (see Fig. 3).
ICP6-FL mice also had background bioluminescence in
paws, tail, and ears that was similar to that observed in TK-FL
mice (data not shown). However, ICP6-FL mice showed no
detectable change in luciferase activity following corneal
infection with 1 × 106 pfu strain 17 or strain KOS (data not
shown). Based on these data for TK-FL and ICP6-FL mice, we
used transgenic line 4 of TK-FL mice for further BLI studies of
HSV-1 infection. Line 4 of TK-FL mice was selected based on
its relatively low background level of bioluminescence and high
induction of FL activity at the site of infection. These mice are
designated as TK-FL reporter mice.
Ocular infection with HSV-1 strains
One of the primary objectives in developing the TK-FL
reporter mouse was to enable imaging studies of different
strains of HSV-1 without producing new recombinant viruses.
To determine the extent to which the TK-FL mouse functions as
a general reporter for HSV-1 infection, we infected mice with
1 × 106 pfu of KOS, 17, or McKrae in the right eye. As a control
for non-specific induction of FL, mice were mock-infected in
the left eye. Progression of infection was detected and
quantified with daily BLI studies.Mice from each line of transgenic mice were infected via corneal scarification in
rom each founder line are shown prior to infection and on day 5 after infection.
ce is presented as a pseudocolor scale, with red and blue representing the highest
se (n = 3 total) from TK-FL founder line 4 on day 5 after corneal infection with
Fig. 3. Infection of TK-FL transgenic mice with HSV-1 strains KOS (A), 17 (B), or McKrae (C). Mice were infected with 1 × 106 pfu of virus in the right eye or mock-
infected in the left eye. Representative BLI images are shown over the course of infection. Images in C also show the mock-infected left eye and a dorsal view of an
infected mouse. Images in which light from the paws reflects off the chin are denoted with a white asterisk. (D) Photon flux produced by each strain of HSV-1 in TK-FL
mice over the course of acute infection. Data for photon flux are mean values ± SEM for n = 5–6 mice per group. (E) Area-under-the-curve (AUC) analysis of total
photon flux for mice infected with various strains of HSV-1. * Denotes P b 0.05 and ** denotes P b 0.001.
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(Figs. 3A–C). This activity likely was due to virus draining
from the infected eye to the nasopharynx and oropharynx via
the nasolacrimal duct, although it potentially could be due to
the host response to infection. For strains 17 and McKrae,
bioluminescence in the mouth was detected on days 1–2 post-
infection, while this could not be detected confidently until
day 3 for mice infected with KOS. It is important to note that
careful positioning of the front paws was necessary to prevent
bioluminescence from reflecting off the mouth of mice
(compare days 0 and 1 in Fig. 3A). Minimal bioluminescence
in the infected right eye could be seen with BLI on day 2
post-infection, but FL activity in the eye and periocular
tissues more typically was observed on day 3 for all strains of
virus. As expected from our previous studies with KOS/dlux,
bioluminescence peaked on days 5–6 post-infection, at which
time most of the FL activity was present in periocular tissues.
No bioluminescence could be detected in the uninfected left
eye of these adult mice (Fig. 3C). FL activity at the site ofinfection decreased to approximately baseline levels on day 7
post-infection for strains KOS and 17, while bioluminescence
was detectable through day 8 in TK-FL mice infected with
strain McKrae. Overall, the general spatial and temporal
changes in bioluminescence reproduced the established
progression of HSV-1 infection in mice, demonstrating that
the TK-FL reporter mice can be used for BLI studies of
pathogenesis.
We used ROI analysis to quantify relative increases in
amounts of bioluminescence produced in response to
infection with various strains of HSV-1 (Fig. 3D). Increases
in bioluminescence were greatest for infection with strain
McKrae. Peak levels of FL activity increased by approxi-
mately 125-fold for strain McKrae, while amounts of
bioluminescence were approximately 26- and 9-fold above
background for strains 17 and KOS, respectively. The total
increase in bioluminescence produced by infection with the
various strains of HSV-1 was quantified by area-under-the-
curve (AUC) analysis of photon flux data (Fig. 3E). Total
Fig. 4. Bilateral spread of infection in young mice. Three-week-old TK-FL mice
were infected with 1 × 106 pfu strain McKrae in the right eye, while the left eye
was untreated. Representative images from 2 different mice on days 4 and 5 after
infection show bioluminescence in periocular tissues and eyes bilaterally
(arrows).
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periocular tissues, was significantly greater for TK-FL mice
infected with McKrae, as evidenced by AUC values that were
approximately 5- and 10-fold greater than determined for
strains 17 (P b 0.005) and KOS (P b 0.001), respectively.
AUC over the period of acute infection with strain 17 also
was significantly greater than KOS (P b 0.05). These data
suggest that amounts of bioluminescence correspond to
relative virulence of these three viruses, although we cannot
exclude the possibility that activity of the reporter is affected
by differences in host response to infection.
Infections described above were performed in adult mice
ranging in age from 7 to 10 weeks old. To investigate the
extent to which infection with HSV-1 is affected by age of
mice, we infected 3-week-old mice with strain McKrae. At 3
weeks of age, immune systems of mice are reported to be
mature (Martinez et al., 1999). Mice were infected in the
right eye with 1 × 106 pfu of strain McKrae, while the left
eye was intentionally not infected or mock-infected.
Increases in bioluminescence in the infected right eye and
periocular tissues occurred as expected from studies with
adult animals (Fig. 4). Unlike adult mice, we also noted that
luciferase activity in 3 of 5 mice increased in periocular
tissues on the left with intensities that were similar to those
on the infected right side. While we cannot exclude the
possibility that luciferase activity on the left side is activated
solely by the host response, these results suggest that spread
of infection to the contralateral side may occur in this
younger population of mice. Collectively, these data with
ocular infection indicate that BLI of the TK-FL reporter
mouse can detect and quantify infection with multiple wild-
type strains of HSV-1.
Bioluminescence response to various input titers of virus
Having determined that infection of TK-FL mice with
different strains of HSV-1 could be detected with in vivo
imaging, we next investigated to what extent imaging data
could differentiate among different input titers of virus used for
infection. We infected mice via corneal scarification with input
titers of strain McKrae between 1 × 103 and 1 × 106 pfu in the
right eye. The left eye of each mouse was mock-infected as a
control. BLI was performed daily for 8 days to monitor acute
infection, and data for increases in bioluminescence in the
infected right eye and periocular tissues of each mouse relative
to the same area in the mock-infected left eye were quantified by
ROI analysis.
BLI data showed that infection with increasing input titers
of strain McKrae produced proportionate increases in
bioluminescence over the course of acute infection (Fig.
5A). Using strain McKrae, input titers of 1 × 103 pfu were
detectable over background levels in the TK-FL reporter
mice. AUC analysis of total photon flux showed statistically
significant differences in bioluminescence among various
input titers of virus, demonstrating that the reporter mouse
can be used to distinguish graded amounts of HSV-1 in vivo
(Fig. 5B) (P b 0.01).To extend these observations to another strain of HSV-1,
we also infected TK-FL mice with different input titers of
strain 17 via corneal scarification (Fig. 5C). Similar to results
with McKrae, BLI data for photon flux at the site of ocular
infection increased as more strain 17 were used for infection.
Bioluminescence produced by infection with 1 × 104 and
1 × 105 pfu of strain 17, respectively, was lower than that
produced 1 × 106 pfu (see Figs. 3B and D), although the
latter amount of virus was not compared directly in this
experiment. For strain 17, an input titer of 1 × 104 pfu was
detectable with BLI, but an inoculum of 1 × 103 pfu could
not be measured reliably above background. AUC analysis
confirmed a statistically significant difference in photon flux
measured in TK-FL mice infected with 1 × 104 and 1 × 105
pfu, respectively (Fig. 4D) (P b 0.05). The sensitivity of the
reporter mouse for infection is less than that reported with our
recombinant strain KOS virus that expresses firefly luciferase
(KOS/dlux) (Luker et al., 2002). Nevertheless, these data
confirm the direct relationship between input titers of two
different strains of HSV-1 and bioluminescence produced
during the period of acute infection in TK-FL mice.
Cutaneous infection with HSV-1 in the flank
We used a cutaneous route of infection to determine the
extent to which the TK-FL reporter mice could be used to
monitor a second route of infection. Fur overlying both flanks of
mice was removed with clippers and Nair, and the skin was
abraded gently with a Dremel tool to facilitate infection (Stock
et al., 2004). Animals were infected with 1 × 106 pfu strain 17 in
the right flank, while the left flank was mock-infected as a
control. Daily BLI studies showed that a low level of
bioluminescence could be detected at the site of flank infection
on day 2 (Fig. 6A). The amount and distribution of FL activity
increased progressively through day 4 and subsequently
returned to baseline by day 6. By comparison, only minimal
bioluminescence was observed in the mock-infected left flank
on day 4 (Fig. 6A and data not shown). ROI analysis of photon
flux verified the increase and subsequent decrease in FL activity
during acute infection, showing that the reporter mouse can
Fig. 5. Increases in viral titers used for infection produce proportionate increases in bioluminescence. TK-FL mice were infected in the right eye with various titers of
HSV-1 strains McKrae (A, B) or 17 (C and D). BLI data for changes in photon flux at the site of infection were quantified by ROI analysis. Data are presented as mean
values ± SEM for photon flux on each day of acute infection (n = 4 per condition) (A and C) or overall photon flux as determined by AUC analysis (B and D). Note
differing scales for AUC data in C and D. Dotted line in A and C represents background photon flux. * Denotes P b 0.05 and ** denotes P b 0.01.
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infection.
Discussion
Studies by our laboratory and others have demonstrated that
in vivo BLI is an important new technology for studying
pathogenesis of viral and bacterial pathogens (reviewed in
Doyle et al., 2004). Previous imaging studies of host–pathogen
interactions have been accomplished with recombinant viruses
or bacteria that have been engineered to express luciferase
enzymes as reporters. This strategy has several limitations, such
as possible attenuation of the pathogen by insertion of the
reporter gene and the time required to construct recombinant
viruses or bacteria. These potential problems decrease the
ability of investigators to study various strains of the same
pathogen or effects of mutations in genes of interest.
We have developed a transgenic reporter mouse that uses the
promoter from HSV-1 thymidine kinase to control expression of
FL, thereby overcoming these limitations for using BLI to
monitor HSV-1 infection. Bioluminescence at the site of
infection increased in response to HSV-1 infection, but no
change in activity of FL was detected following infection with
vaccinia virus, an unrelated DNA virus. Infections with strains
KOS, 17, and McKrae all were detected with BLI, and relative
amounts of bioluminescence increased in accordance with the
rank order of virulence of these three strains. Changes in
bioluminescence at the site of infection were proportional toinput titers of virus, showing that the TK-FL mouse can
distinguish among different amounts of virus in vivo. These
data support our conclusion that luciferase activity corresponds
directly with viral replication, although it is possible that
differences in host response to infection contribute to overall
changes in bioluminescence. Collectively, these data show that
the TK-FL mouse is a general tool for assaying HSV-1 infection
in mouse models.
Our data show that TK-FL mice can be used to monitor
infection with HSV-1 in the corneal and flank models of
infection. Both of these routes of infection have been used to
investigate key aspects of viral–host pathogenesis during acute
infection and reactivation from latency (Van Lint et al., 2004;
Leib et al., 2000; Liu et al., 2000). Because the TK-FL mouse
allows infections with strains 17 and McKrae to be investigated
in vivo, this reporter mouse offers the potential for in vivo
studies of viral and host factors that affect reactivation from
latency. The ability to study this important aspect of HSV-1
pathogenesis in living mice may provide new insights into
mechanisms that regulate this process and allow in vivo testing
of new methods to prevent or limit reactivation.
In 3-week-old TK-FL mice, we determined that biolumines-
cence commonly could be detected in the uninfected eye in
addition to the infected eye after corneal scarification. Previous
studies have demonstrated interocular spread of HSV-1 from an
infected to uninfected eye after injection of virus into the
anterior chamber (Whittman et al., 1984; Atherton and Streilein,
1987; Geiger et al., 1994). In the anterior chamber model of
Fig. 6. Cutaneous infection of TK-FL reporter mice. TK-FL mice were infected on the right flank with 1 × 106 pfu HSV-1 strain 17 or mock-infected on the left flank.
(A) BLI images show the progression of acute infection at the site of infection. The mock-infected left flank is shown on day 4 post-infection, which was the only time
point with detectable bioluminescence above background levels. (B) Mean values ± SEM for photon flux at the site of infection with strain 17 (n = 4 mice).
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infection, while a second wave of virus in the eye occurs 7–10
days after infection. The delayed wave of HSV-1 in the
uninfected eye is due to trafficking via the optic nerve, but the
route for initial interocular spread of HSV-1 is characterized
poorly. To our knowledge, a similar process has not been
reported for spread of HSV-1 to the uninfected eye in young
mice. Although the mechanism for this process in 3-week-old
mice currently is unknown, the appearance of luciferase activity
in the uninfected eye by 4 days after infection does not appear to
be consistent with the kinetics of spread via the optic nerves.
Although the TK promoter generally is regarded to be active
constitutively (Hua et al., 1996), the TK-FL reporter showed
robust induction of bioluminescence in response to infection
with HSV-1. The strong expression of luciferase after infection
emphasizes that TK and all other early genes in HSV-1 are
regulated by immediate early genes. By comparison, the ICP6
promoter, which typically is considered as an inducible
promoter, did not respond to infection in 3 different lines of
transgenic mice. Several different factors may account for the
differences between these 2 different transgenic reporter mice. It
has been established that HSV-1 can have differing effects on
regulation of genes integrated into the viral versus cellular
genomes (Smibert and Smiley, 1990). Expression of transgenes
also is affected by position in the cellular genome. We did not
investigate integration sites of the ICP6-FL transgene in mousechromosomes, so it is possible that the reporter was repressed in
all 3 lines of mice bearing this reporter construct. Finally, we
cannot completely exclude that differences in strains of mice
affected activation of the TK-FL and ICP6-FL reporters,
respectively, although other transgenic mice have been
established successfully in the CD-1 strain (Tsoporis et al.,
1998).
The existing TK-FL mouse was analyzed in a mixed genetic
background of C57BL/6-C3H. While this hybrid strain enabled
successful establishment of transgenic founder mice, there are a
limited number of genetically altered mice in this same
background. Mating the existing TK-FL mice to other mice
with specific mutations or deletions in key immunoregulatory
genes is expected to further enhance the uses of the reporter
mouse for studies of HSV-1 pathogenesis.
Our data demonstrate that the TK-FL reporter mouse can be
used to detect infection with various strains of HSV-1, but
there are limitations to this transgenic mouse relative to
reporter viruses engineered to express FL. The lower limits of
detection for ocular infection with the TK-FL mouse are an
input titer of 1 × 103 pfu, which is approximately 10-fold
higher than the minimum titer of KOS/dlux that can be
detected with BLI (Luker et al., 2002). The decreased
sensitivity of the reporter mouse also is evident in the time
interval between infection and initial detection of biolumines-
cence with imaging. HSV-1 infection first can be detected on
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of bioluminescence are observed in the eye on day 1 after
infection with KOS/dlux (Luker et al., 2002). These data imply
that numbers of copies of reporter DNA, transcription, and/or
translation of FL are greater when the reporter is integrated
into the viral genome as compared with the host. We also noted
that bioluminescence was detected in the mouth of infected
mice, a finding that was not observed in previous studies with
the recombinant strain KOS virus that expresses firefly
luciferase (Luker et al., 2002, 2003). Potentially, this may be
due to the use of a slightly larger volume of medium for
infecting eyes in the current study, although we cannot exclude
the possibility that reporter activity in the mouth is regulated
by a cellular response to infection. It also is possible that
differences in distribution of bioluminescence may be
attributed to variations between strains of mice.
The transgenic reporter mouse also has relatively high levels
of FL activity in paws, ears, and the tail under basal conditions.
These sites of background bioluminescence have been observed
in other transgenic mice that use FL as a reporter gene (Ryan
and Scrable, 2004). FL activity in the skin is detected more
readily with BLI because there is minimal attenuation by
intrinsic pigmentation of organs or overlying fur. Potentially,
bioluminescence may be greater in these sites because of
slightly lower body temperature in the extremities of mice. FL is
heat labile with a biologic half-life of approximately 3 min at 37
°C (Baggett et al., 2004), so small decreases in temperature in
superficial tissues could stabilize the protein and increase
bioluminescence. While background bioluminescence did not
limit BLI studies of infection in the eye or flank, these mice will
have limited usefulness for imaging the footpad route of
infection.
In summary, we have established a transgenic reporter mouse
that expresses FL in response to HSV-1 infection. The TK-FL
mouse shows titer-dependent production of bioluminescence
and responds to three commonly used laboratory strains of
HSV-1. This reporter mouse allows BLI studies of HSV-1
without the need to make a reporter virus, thereby enabling in
vivo imaging studies of existing strains and mutants of HSV-1.
We anticipate that the TK-FL mouse will complement our
existing reporter virus (KOS/dlux) as important tools for
investigating HSV-1 pathogenesis and testing new antiviral
therapies.
Materials and methods
Plasmids
A fragment containing bases −121 to +52 of the promoter for
HSV-1 thymidine kinase was excised from TK-luciferase (gift
of Stuart Adler, Washington University) with EcoRI and NotI
and ligated to the SmaI site of pGL3 basic (Promega) to
generate TK-pGL3. The promoter for HSV-1 ICP6 was
removed from pGL2 basic (Promega) (gift of Paul Olivo)
with SmaI and HindIII and ligated to the corresponding sites in
pGL3 basic to produce ICP6-pGL3. The promoter and FL were
removed from TK-pGL3 and ICP6-pGL3, respectively, withNotI and XbaI. This fragment of DNA (TK-FL) was isolated
and purified with a Qiaex II kit (Qiagen) to inject for production
of transgenic mice. A FL reporter plasmid containing the
promoter for ICP8 has been described previously (Summers et
al., 2001).
Cells
293T and Vero cells were cultured in DMEM medium with
10% heat-inactivated fetal bovine serum, 1% L-glutamine, and
0.1% penicillin–streptomycin in a 5% CO2 incubator at 37 °C.
Viruses
HSV-1 strains KOS, 17, and McKrae were propagated and
titrated on Vero cells as described (Rader et al., 1993). The
recombinant strain KOS virus expressing FL from the ICP8
promoter (KOS/dlux) has been characterized previously
(Summers et al., 2001). Western Reserve (WR) vaccinia virus
(gift of Andrew Pekosz, Washington University) was propa-
gated, purified, and titered according to published protocols
(Earl et al., 1998).
In vitro assays of luciferase reporters
293T or Vero cells were plated at 35,000 cells per well in 24-
well plates 1 day prior to transfection with 1 μg of various HSV-
1 promoter reporter constructs. Transfections were performed
with Fugene 6 (Roche). Twenty-four hours after transfection,
cells were infected with HSV-1 strain KOS at an MOI of 1 or 5.
Cells were lysed 24 h after infection, and amounts of firefly
luciferase activity were quantified with a luciferase assay kit
(Promega) and a luminometer (Turner). Data for luciferase
activity were expressed as relative light units per mg protein as
measured by BCA assay (Pierce).
Transgenic mice
Transgenic mice carrying either the TK-FL or ICP6-FL
reporter were prepared by the core facility in the Department of
Ophthalmology and Visual Sciences at Washington University
School of Medicine. TK-FL mice were a hybrid strain of
C57BL/6-C3H mouse, while ICP6-FL transgenic mice were in
a CD-1 strain. Founder mice bearing the transgene were
identified by PCR analysis of tail samples, using the primers
forward 5′ AGACGCCAAAAACATAAAGAAAGG-
CCCGGC 3′ and reverse 5′ AGACGCCAAAAACATAAAG-
AAAGGCCCGGC 3′. Four different TK-FL transgenic mice
and 3 lines of ICP6-FL mice were obtained, respectively.
Transgenic mice from each founder line were characterized for
induction of luciferase activity in response to infection with
HSV-1. The line of transgenic mice with highest induction of
luciferase following infection was used for subsequent experi-
ments. For these mice, transgenic pups were identified by
bioluminescence imaging for the presence of bioluminescence
in paws of uninfected mice after intraperitoneal injection of D-
luciferin.
294 K.E. Luker et al. / Virology 347 (2006) 286–295Infection of mice
Mice were infected with HSV-1 strains KOS, 17, or McKrae
at titers between 1 × 103 and 1 × 106 pfu as indicated in figure
legends. Animals were between 7 and 10 weeks old at the time
of experiments, except for the specific experiment that analyzed
ocular infection with strain McKrae in 3-week-old mice. Ocular
infections were performed by corneal scarification followed by
administration of virus in 2.5 μL of DMEM medium
(Invitrogen) (Rader et al., 1993). For flank infection with
HSV-1, hair was removed from mice with electric clippers and
Nair. The skin was abraded with a Dremel tool and infected with
1 × 103 to 1 × 106 pfu in 20 μL DMEM according to a published
protocol (Stock et al., 2004). A sterile bandage was kept over
the site of infection for the first 24 h.
Bioluminescence imaging
Bioluminescence imaging was performed with a cryogeni-
cally cooled CCD camera (IVIS, Xenogen). Acquisition and
analysis of images were performed as described previously
(Luker et al., 2002).
Data analysis
Data for in vitro and in vivo experiments are reported as
mean values ± SEM. Data were analyzed by t test to determine
statistically significant differences (P b 0.05) using Graphpad
software (Prism).
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